In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Senti Biosciences Inc. (NASDAQ: SNTI) was $0.31 for the day, down -20.51% from the previous closing price of $0.39. In other words, the price has decreased by -$20.51 from its previous closing price. On the day, 1.99 million shares were traded. SNTI stock price reached its highest trading level at $0.3676 during the session, while it also had its lowest trading level at $0.3118.
Ratios:
Our analysis of SNTI’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.79 and its Current Ratio is at 5.79. In the meantime, Its Debt-to-Equity ratio is 0.65 whereas as Long-Term Debt/Eq ratio is at 0.58.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on October 07, 2022, initiated with a Equal-Weight rating and assigned the stock a target price of $7.50.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SNTI now has a Market Capitalization of 14870374 and an Enterprise Value of 27778382. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.17 while its Price-to-Book (P/B) ratio in mrq is 0.25. Its current Enterprise Value per Revenue stands at 21.787 whereas that against EBITDA is -0.461.
Stock Price History:
The Beta on a monthly basis for SNTI is 2.76, which has changed by -0.5 over the last 52 weeks, in comparison to a change of 0.25510752 over the same period for the S&P500. Over the past 52 weeks, SNTI has reached a high of $1.09, while it has fallen to a 52-week low of $0.21. The 50-Day Moving Average of the stock is -3.84%, while the 200-Day Moving Average is calculated to be -20.90%.
Shares Statistics:
SNTI traded an average of 7.19M shares per day over the past three months and 44776690 shares per day over the past ten days. A total of 45.70M shares are outstanding, with a floating share count of 27.77M. Insiders hold about 39.32% of the company’s shares, while institutions hold 8.81% stake in the company. Shares short for SNTI as of 1718323200 were 270712 with a Short Ratio of 0.04, compared to 1715731200 on 281367. Therefore, it implies a Short% of Shares Outstanding of 270712 and a Short% of Float of 0.75.
Earnings Estimates
On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$0.42. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 1 analysts. It ranges from a high estimate of $300k to a low estimate of $300k. As of the current estimate, Senti Biosciences Inc.’s year-ago sales were $59k
A total of 1 analysts have provided revenue estimates for SNTI’s current fiscal year. The highest revenue estimate was $3.46M, while the lowest revenue estimate was $3.46M, resulting in an average revenue estimate of $2.56M. In the same quarter a year ago, actual revenue was $4.29MBased on 2 analysts’ estimates, the company’s revenue will be $8.9M in the next fiscal year. The high estimate is $14M and the low estimate is $3.8M.
